Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 70511-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70511-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Maia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl Image 2 100 Mcg Vial Label (Spl Image2 Vial 100mcg)
Spl Image 3 200 Mcg Vial Label (Spl Image3 Vial 200mcg)
This appears to be a pharmaceutical description for Levothyroxine Sodium for injection, containing 200 mcg in a single-use vial for intravenous use. The product is marked for prescription-only use, and there are specific instructions to discard any unused portions. There is no information available regarding its indications or side effects.*
Spl Image 4 500 Mcg Vial Label (Spl Image4 Vial 500mcg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.